GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » DeferredTaxAndRevenue

G.Barekat Pharm (XTEH:BRKT1) DeferredTaxAndRevenue : IRR0 Mil (As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

G.Barekat Pharm's current deferred tax and revenue for the quarter that ended in Mar. 2017 was IRR0 Mil.

G.Barekat Pharm DeferredTaxAndRevenue Historical Data

The historical data trend for G.Barekat Pharm's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm DeferredTaxAndRevenue Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
DeferredTaxAndRevenue
- -

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
DeferredTaxAndRevenue - -

G.Barekat Pharm DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


G.Barekat Pharm (XTEH:BRKT1) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines